Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon during Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients

Triple therapy combining a protease inhibitor (PI) (telaprevir or boceprevir), pegylated interferon (PEG-IFN), and ribavirin (RBV) has dramatically increased the chance of eradicating hepatitis C virus (HCV). However, the efficacy of this treatment remains suboptimal in cirrhotic treatment-experienc...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Laouénan, Cédric, Marcellin, Patrick, Lapalus, Martine, Khelifa-Mouri, Feryel, Boyer, Nathalie, Zoulim, Fabien, Serfaty, Lawrence, Bronowicki, Jean-Pierre, Martinot-Peignoux, Michelle, Lada, Olivier, Asselah, Tarik, Dorival, Céline, Hézode, Christophe, Carrat, Fabrice, Nicot, Florence, Peytavin, Gilles, Mentré, France, Guedj, Jeremie
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Microbiology 2014
الموضوعات:
Antiviral Agents
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4135822/
https://ncbi.nlm.nih.gov/pubmed/24982076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02611-14
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة